146 related articles for article (PubMed ID: 33256303)
21. Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening.
Zhao G; Li H; Yang Z; Wang Z; Xu M; Xiong S; Li S; Wu X; Liu X; Wang Z; Zhu Y; Ma Y; Fei S; Zheng M
Cancer Med; 2019 Sep; 8(12):5619-5628. PubMed ID: 31407497
[TBL] [Abstract][Full Text] [Related]
22. piR-823 demonstrates tumor oncogenic activity in esophageal squamous cell carcinoma through DNA methylation induction via DNA methyltransferase 3B.
Su JF; Zhao F; Gao ZW; Hou YJ; Li YY; Duan LJ; Lun SM; Yang HJ; Li JK; Dai NT; Shen FF; Zhou FY
Pathol Res Pract; 2020 Apr; 216(4):152848. PubMed ID: 32051106
[TBL] [Abstract][Full Text] [Related]
23. Methylation of the SEPT9_v2 promoter as a novel marker for the detection of circulating tumor DNA in breast cancer patients.
Matsui S; Kagara N; Mishima C; Naoi Y; Shimoda M; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Oncol Rep; 2016 Oct; 36(4):2225-35. PubMed ID: 27499429
[TBL] [Abstract][Full Text] [Related]
24. Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma.
Yu J; Yuan X; Sjöholm L; Liu T; Kong F; Ekström TJ; Björkholm M; Xu D
Cancer Lett; 2018 Oct; 434():33-41. PubMed ID: 30017965
[TBL] [Abstract][Full Text] [Related]
25. Expression of DNA methyltransferases and target microRNAs in human tissue samples related to sporadic colorectal cancer.
Huang C; Liu H; Gong XL; Wu L; Wen B
Oncol Rep; 2016 Nov; 36(5):2705-2714. PubMed ID: 27666771
[TBL] [Abstract][Full Text] [Related]
26. Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study.
Bergheim J; Semaan A; Gevensleben H; Groening S; Knoblich A; Dietrich J; Weber J; Kalff JC; Bootz F; Kristiansen G; Dietrich D
Br J Cancer; 2018 May; 118(9):1217-1228. PubMed ID: 29610456
[TBL] [Abstract][Full Text] [Related]
27. Prostaglandin E
Wong CC; Kang W; Xu J; Qian Y; Luk STY; Chen H; Li W; Zhao L; Zhang X; Chiu PW; Ng EK; Yu J
Theranostics; 2019; 9(21):6256-6268. PubMed ID: 31534549
[No Abstract] [Full Text] [Related]
28. [Effect of stable DNA methyltransferase 3bknockdown on proliferation and apoptosis in bladder cancer cells in vitro].
Chen K; Li BK; Xu K; Xu A; Liu C; Zheng S; Xu Y; Jia C; Liu Q; Li H
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Nov; 35(11):1524-9. PubMed ID: 26607069
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation status of hMLH1, p16(INK4a), and CDH1 is not associated with mRNA expression levels of DNA methyltransferase and DNA demethylase in gastric carcinomas.
Oue N; Kuraoka K; Kuniyasu H; Yokozaki H; Wakikawa A; Matsusaki K; Yasui W
Oncol Rep; 2001; 8(5):1085-9. PubMed ID: 11496321
[TBL] [Abstract][Full Text] [Related]
30. Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA.
Tóth K; Wasserkort R; Sipos F; Kalmár A; Wichmann B; Leiszter K; Valcz G; Juhász M; Miheller P; Patai ÁV; Tulassay Z; Molnár B
PLoS One; 2014; 9(12):e115415. PubMed ID: 25526039
[TBL] [Abstract][Full Text] [Related]
31. Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future.
Li Y; Song L; Gong Y; He B
Biomark Med; 2014; 8(5):755-69. PubMed ID: 25123042
[TBL] [Abstract][Full Text] [Related]
32. A systematic review of the performance of the SEPT9 gene methylation assay in colorectal cancer screening, monitoring, diagnosis and prognosis.
Song L; Yu H; Jia J; Li Y
Cancer Biomark; 2017; 18(4):425-432. PubMed ID: 28128742
[TBL] [Abstract][Full Text] [Related]
33. Antiproliferative effects of DNA methyltransferase 3B depletion are not associated with DNA demethylation.
Hagemann S; Kuck D; Stresemann C; Prinz F; Brueckner B; Mund C; Mumberg D; Sommer A
PLoS One; 2012; 7(5):e36125. PubMed ID: 22563479
[TBL] [Abstract][Full Text] [Related]
34. Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression.
Connolly D; Yang Z; Castaldi M; Simmons N; Oktay MH; Coniglio S; Fazzari MJ; Verdier-Pinard P; Montagna C
Breast Cancer Res; 2011 Aug; 13(4):R76. PubMed ID: 21831286
[TBL] [Abstract][Full Text] [Related]
35. The SEPT9 gene methylation assay is capable of detecting colorectal adenoma in opportunistic screening.
Song L; Peng X; Li Y; Xiao W; Jia J; Dong C; Gong Y; Zhou G; Han X
Epigenomics; 2017 May; 9(5):599-610. PubMed ID: 28470092
[TBL] [Abstract][Full Text] [Related]
36. Application of droplet digital polymerase chain reaction of plasma methylated septin 9 on detection and early monitoring of colorectal cancer.
Ma ZY; Chan CSY; Lau KS; Ng L; Cheng YY; Leung WK
Sci Rep; 2021 Dec; 11(1):23446. PubMed ID: 34873218
[TBL] [Abstract][Full Text] [Related]
37. Progress on the clinical application of the SEPT9 gene methylation assay in the past 5 years.
Song L; Li Y
Biomark Med; 2017 May; 11(6):415-418. PubMed ID: 28617104
[No Abstract] [Full Text] [Related]
38. Diurnal expression of Dnmt3b mRNA in mouse liver is regulated by feeding and hepatic clockwork.
Maekawa F; Shimba S; Takumi S; Sano T; Suzuki T; Bao J; Ohwada M; Ehara T; Ogawa Y; Nohara K
Epigenetics; 2012 Sep; 7(9):1046-56. PubMed ID: 22847467
[TBL] [Abstract][Full Text] [Related]
39. Gene-specific DNA methylation of DNMT3B and MTHFR and colorectal adenoma risk.
Ho V; Ashbury JE; Taylor S; Vanner S; King WD
Mutat Res; 2015 Dec; 782():1-6. PubMed ID: 26485042
[TBL] [Abstract][Full Text] [Related]
40. Genetic and epigenetic variation in the DNMT3B and MTHFR genes and colorectal adenoma risk.
Ho V; Ashbury JE; Taylor S; Vanner S; King WD
Environ Mol Mutagen; 2016 May; 57(4):261-8. PubMed ID: 27062459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
